MD Anderson Experts Highlight Breakthrough Immunotherapy Advances at 2025 SITC Annual Meeting
As cancer treatment continuously evolves, immunotherapy remains at the forefront of transformative advances. At the 2025 Society for Immunotherapy of ...
As cancer treatment continuously evolves, immunotherapy remains at the forefront of transformative advances. At the 2025 Society for Immunotherapy of ...
In a breakthrough study that may revolutionize cancer treatment paradigms, researchers at Cincinnati Children’s have uncovered a critical genetic mutation ...
A groundbreaking phase II clinical trial named AXIOM is set to explore an innovative combination of stereotactic body radiotherapy (SBRT) ...
In a landmark discovery that could alter the course of cancer treatment, researchers at The University of Texas MD Anderson ...
In a groundbreaking study published in Nature Communications, researchers uncover how the interplay between inflammation and mutational burden distinctly influences ...
(Barcelona, Spain – September 8, 2025, 10:45 a.m. CEST / UTC +2) — In a pivotal development presented at the ...
In a groundbreaking advancement for the management of advanced non-small cell lung cancer (NSCLC) harboring epidermal growth factor receptor (EGFR) ...
In a groundbreaking real-world study published in BMC Cancer, researchers have unveiled compelling evidence supporting the survival benefits of combining ...
In the rapidly evolving field of oncology, one of the most perplexing challenges remains the management of cancer of unknown ...
In recent years, the landscape of oncology has undergone a transformative evolution, particularly in the treatment of rectal cancer. Traditional ...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine